Regulation Of Emissions From Biotech Facilities.

REGULATION OF EMISSIONS FROM BIOTECHNOLOGY FACILITIES

INTRODUCTION

Biotechnology facilities conduct activities involving microorganisms, biological materials, fermentation, pharmaceutical production, laboratory research, and biomedical waste treatment. Their operations may generate air pollutants, greenhouse gases, odours, hazardous vapours, contaminated aerosols, and emissions from incineration or energy-intensive manufacturing processes. Inadequate controls can endanger workers, surrounding communities, and the environment.

Regulation of emissions from biotechnology facilities therefore combines environmental pollution control, occupational safety, biosafety, waste management, and industrial licensing. In India, the legal framework principally derives from the Environment (Protection) Act, 1986, the Air (Prevention and Control of Pollution) Act, 1981, and applicable rules and regulatory directions.

1. LEGAL AND REGULATORY FRAMEWORK

A. ENVIRONMENT (PROTECTION) ACT, 1986

The Act empowers the Central Government to prescribe environmental standards, regulate industrial operations, and take measures to prevent environmental pollution. Sections 7 and 8 address compliance with prescribed emission standards and safeguards for handling hazardous substances. Section 5 provides powers to issue directions, including directions concerning the regulation or closure of industries, subject to law.

Biotechnology facilities must identify the standards applicable to their particular activities and equipment.

B. AIR (PREVENTION AND CONTROL OF POLLUTION) ACT, 1981

Sections 21 and 22 are important provisions concerning consent requirements for industrial plants in air pollution control areas and compliance with prescribed emission standards. State Pollution Control Boards may impose consent conditions and take enforcement action under the Act.

C. BIO-MEDICAL WASTE MANAGEMENT RULES, 2016

These Rules apply to specified biomedical waste generated by healthcare establishments and research laboratories. They prescribe segregation, treatment, disposal, and other management requirements. Schedule II establishes operating and emission standards for relevant treatment technologies, including incineration. Applicable requirements include periodic stack monitoring and continuous emissions monitoring where stipulated by the Rules and the competent authority.

The rules governing hazardous microorganisms and genetically engineered organisms may also apply to specified biotechnology activities. The applicable regime depends on the organism, process, facility, and potential environmental risk.

2. PRINCIPAL COMPLIANCE OBLIGATIONS

A. EMISSION CONTROL: Facilities should identify emission sources, install appropriate filtration and treatment systems, maintain equipment, and comply with applicable stack-emission limits.

B. MONITORING AND REPORTING: Operators should conduct required emission testing, maintain records, report specified incidents, and submit information to the competent authority.

C. BIOSAFETY: Where biological aerosols or hazardous microorganisms may be released, containment, ventilation, decontamination, and validated treatment procedures should be implemented according to the applicable risk classification and legal requirements.

D. WASTE MANAGEMENT: Biological waste must be segregated, treated, transported, and disposed of in accordance with applicable rules. Incinerators must satisfy prescribed operating conditions and emission standards.

E. ENVIRONMENTAL AUTHORISATIONS: Depending on the project, facilities may require environmental clearance, consent to establish, consent to operate, or specific authorisations. These requirements are not identical for every biotechnology facility.

3. RELEVANT CASE LAWS

1. M.C. Mehta v. Union of India (Oleum Gas Leak Case), (1987) 1 SCC 395

Authority: Direct to hazardous industrial operations; analogous to biotechnology emissions. The Supreme Court developed the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities when harm results from their operations.

Relevance: Biotechnology operators undertaking hazardous industrial processes must take appropriate precautions and cannot assume that ordinary negligence standards exhaust their responsibilities.

2. Vellore Citizens' Welfare Forum v. Union of India, (1996) 5 SCC 647

Authority: Direct to environmental protection; analogous to biotechnology facilities. The Supreme Court recognised the precautionary principle and polluter-pays principle as essential features of Indian environmental law.

Relevance: Regulators may require preventive emission controls where credible environmental risks exist, while polluters may be held responsible for environmental damage and remediation.

3. Indian Council for Enviro-Legal Action v. Union of India, (1996) 3 SCC 212

Authority: Direct to industrial pollution liability. The Supreme Court addressed environmental damage caused by hazardous industrial operations and emphasised the responsibility of polluting industries to bear the costs of remedial measures.

Relevance: Biotechnology manufacturers cannot automatically transfer the costs of pollution remediation to the public.

4. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (1999) 2 SCC 718

Authority: Direct to environmental regulatory decision-making. The Court highlighted scientific uncertainty and the importance of expert knowledge in environmental disputes.

Relevance: Decisions concerning biological aerosols, toxic emissions, and uncertain ecological effects should be informed by competent scientific assessment.

5. M.C. Mehta v. Union of India, (1987) 4 SCC 463

Authority: Direct to industrial air pollution; analogous to biotechnology facilities. In proceedings concerning industrial pollution in Delhi, the Supreme Court addressed measures to control emissions and protect public health.

Relevance: Industrial operations must comply with legally prescribed pollution controls, and authorities may intervene when emissions threaten public health.

6. Alembic Pharmaceuticals Ltd. v. Rohit Prajapati, (2020) 17 SCC 157

Authority: Direct to environmental clearance compliance; analogous to emissions regulation. The Supreme Court examined ex post facto environmental clearances granted to industrial projects and rejected the assumption that prior environmental requirements could routinely be bypassed.

Relevance: A biotechnology facility should obtain required environmental approvals before commencing regulated operations rather than treating later regularisation as an automatic entitlement.

4. PRACTICAL COMPLIANCE AND ENFORCEMENT

Facilities should prepare an emissions inventory, identify applicable standards, maintain pollution-control equipment, conduct required monitoring, train staff, and preserve inspection records. They should establish procedures for accidental releases and promptly notify authorities where reporting is legally required.

Pollution Control Boards may use inspections, consent conditions, statutory directions, and other enforcement powers to address non-compliance. Depending on the circumstances, violations may lead to penalties, operational restrictions, remediation orders, or prosecution.

CONCLUSION

Regulation of emissions from biotechnology facilities protects public health and environmental quality while enabling responsible scientific and industrial development. Indian environmental legislation establishes obligations concerning emission standards, pollution-control equipment, waste treatment, monitoring, and regulatory approvals. The cited judgments reinforce preventive environmental governance, scientific scrutiny, and responsibility for pollution-related harm. Although these cases do not establish a separate emissions code exclusively for biotechnology, their principles apply to relevant facilities alongside the specific statutory and technical standards governing their operations.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT